Analysts Expect Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) to Post -$0.16 EPS

Retrieved on: 2020-11-26 00:45:00

Tags for this article:

Click the tags to see associated articles and topics

Analysts Expect Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) to Post -$0.16 EPS. View article details on hiswai:

Excerpt

WINTON GROUP Ltd bought a new position in shares of Oramed Pharmaceuticals during the third quarter valued at $74,000. GSA Capital Partners ...

Article found on: www.marketbeat.com